1. Home
  2. HTGC vs LGND Comparison

HTGC vs LGND Comparison

Compare HTGC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hercules Capital Inc.

HTGC

Hercules Capital Inc.

HOLD

Current Price

$16.94

Market Cap

3.2B

Sector

Finance

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$302.15

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTGC
LGND
Founded
2003
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.7B
IPO Year
2004
1997

Fundamental Metrics

Financial Performance
Metric
HTGC
LGND
Price
$16.94
$302.15
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$18.86
★ $256.29
AVG Volume (30 Days)
★ 1.3M
164.8K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
★ 12.13%
N/A
EPS Growth
14.91
★ 2886.36
EPS
0.90
★ 1.63
Revenue
N/A
★ $141,102,000.00
Revenue This Year
$11.18
$1.25
Revenue Next Year
$5.24
$19.41
P/E Ratio
★ $18.67
$183.46
Revenue Growth
N/A
★ 29.48
52 Week Low
$13.70
$166.10
52 Week High
$19.17
$326.63

Technical Indicators

Market Signals
Indicator
HTGC
LGND
Relative Strength Index (RSI) 42.98 65.55
Support Level $16.37 $286.99
Resistance Level $17.15 $317.49
Average True Range (ATR) 0.30 8.66
MACD -0.12 2.57
Stochastic Oscillator 19.77 99.79

Price Performance

Historical Comparison
HTGC
LGND

About HTGC Hercules Capital Inc.

Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: